GlassScriptPhysician profile
Meaghan P Caton
NPI 1134660285
$6,725.03
in general payments reported to CMS, 2019-2025
38 companies · $1,646 in 2025
The $1,646 reported for 2025 was more than what 93% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $1,091 · 2023: $1,913 · 2024: $2,075 · 2025: $1,646.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,568 · Education: $65.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,568.13 |
| Education | $65.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $905.91 | 2022-2025 | Ozempic, Rybelsus, Wegovy |
| Glaxosmithkline, LLC. | $709.29 | 2022-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Lilly USA, LLC | $641.94 | 2022-2025 | Mounjaro, Jardiance, Zepbound |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $490.53 | 2022-2025 | Xifaxan, Trulance, Cycloset |
| Amgen INC. | $465.92 | 2022-2025 | Krystexxa, Repatha, Otezla |
| Astrazeneca Pharmaceuticals LP | $448.39 | 2022-2025 | Airsupra, Farxiga |
| Abbvie INC. | $334.60 | 2022-2025 | |
| Pfizer INC. | $278.45 | 2022-2025 | |
| Abbott Laboratories | $254.83 | 2022-2025 | Freestyle Libre 3 |
| Bayer Healthcare Pharmaceuticals INC. | $242.15 | 2022-2025 | |
| Astellas Pharma US INC | $230.41 | 2022-2025 | Veozah, Myrbetriq |
| Exact Sciences Corporation | $229.23 | 2023-2025 | Cologuard Collection Kit |
| Boehringer Ingelheim Pharmaceuticals, INC. | $200.33 | 2022-2025 | Jardiance, Synjardy, Ofev |
| Ardelyx, INC. | $159.68 | 2024-2025 | Ibsrela |
| Ironwood Pharmaceuticals, INC | $149.43 | 2022-2024 | Linzess |
Show all 38 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Meaghan Caton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.